| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $937.5M | +34.3% |
| Cost of Revenue | $221.3M | +24.4% |
| Gross Profit | $716.2M | +37.7% |
| R&D Expense | $238.5M | -9.0% |
| SG&A Expense | $157.6M | -18.9% |
| Operating Income | -$84.1M | +74.6% |
| Pre-tax Income | -$43.7M | +85.8% |
| Income Tax | $2.5M | +106.5% |
| Net Income | -$46.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $881.5M | +19.3% |
| Accounts Receivable | $43.1M | +86.8% |
| Current Assets | $979.7M | +21.9% |
| Total Assets | $1.27B | +16.9% |
| Current Liabilities | $199.9M | +53.0% |
| Total Liabilities | $239.3M | +37.3% |
| Stockholders' Equity | $1.03B | +13.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $166.0M | +39.0% |
| Capital Expenditures | $5.9M | +62.1% |
| Investing Cash Flow | -$17.2M | -84.1% |
| Financing Cash Flow | -$5.8M | -102.4% |
| Free Cash Flow | $160.0M | +38.3% |
| +85.0% |
| EPS (Basic) | -$0.17 | +86.6% |
| EPS (Diluted) | -$0.17 | +86.6% |